廣告

2014年4月27日 星期日

Glaxo Exits Cancer Drugs

Glaxo Exits Cancer Drugs

Glaxo to Focus on Respiratory and HIV Treatments, Vaccines, Consumer-Health Products

Updated April 22, 2014 8:19 a.m. ET
LONDON—GlaxoSmithKline PLC's decision to leave the hot field of cancer drugs narrows the focus of its business to just four areas: respiratory and HIV treatments, vaccines and consumer-health products.
The move, included in a series of transactions announced Tuesday that will reshape both Glaxo and Novartis AG, is part of a trend for pharmaceutical companies to focus on a handful of "core disease areas" to gain scale and...

沒有留言:

網誌存檔